Ask Warren

L&C Bio

290650 · KOSDAQ · ₩290650 · 엘앤씨바이오

₩23,950▼ ₩1,150 (4.58%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩39B₩30B₩25B₩23B₩20B₩18B₩19B₩19B
Cost of sales₩15B₩12B₩12B₩9.4B₩11B₩7.9B₩9.9B₩9.5B
Gross profit₩24B₩18B₩13B₩13B₩9.3B₩9.8B₩9.2B₩9.1B
Operating income₩8.6B₩6B₩2B₩2.9B−₩1.5M−₩433M−₩622M₩175M
Net income−₩28B₩2.7B−₩72B−₩51B−₩14B−₩642M₩144B−₩5.8B
Net income to shareholders−₩28B₩2.6B−₩73B−₩51B−₩14B−₩428M₩144B−₩5.2B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩477B₩467B₩457B₩498B₩490B₩432B₩476B₩252B
Current assets₩173B₩155B₩139B₩143B₩142B₩90B₩130B₩102B
Cash and equivalents₩36B₩44B₩31B₩31B₩51B₩7.8B₩18B₩21B
Total liabilities₩142B₩254B₩248B₩231B₩166B₩139B₩181B₩98B
Current liabilities₩130B₩244B₩238B₩205B₩136B₩113B₩155B₩92B
Borrowings₩25B₩87B₩86B₩94B₩105B₩120B₩119B₩83B
Total equity₩335B₩213B₩209B₩267B₩324B₩293B₩295B₩154B
Shareholders' equity₩325B₩203B₩198B₩256B₩313B₩283B₩284B₩143B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩8.1B₩8.2B₩6.1B₩3.8B₩1.4B₩1.3B₩360M−₩2.3B
Capital spending₩11B₩7.6B₩8.5B₩2.9B₩3.5B₩910M−₩831M₩3B
Free cash flow−₩2.9B₩610M−₩2.4B₩854M−₩2.1B₩417M−₩471M−₩5.3B
Dividends paid−₩1.8M₩1.2B₩608,100₩0−₩12M₩1.1B₩0₩0

Consolidated where available. Amounts in won.

Also known as: L&C Bio / 엘앤씨바이오 / 290650 / KRX:290650

Source: KRX statistical information